Publication date: September 2026 Source: Immuno-Oncology and Technology, Volume 31 Author(s): J. Kay, M.A. Harris, L.E. Lara Gonzalez, C.T. van Geelen, K.A. Clarke, B. Virassamy, F. Caramia, J.-M. Pang, M.M.R. O’Malley, M.L. Hun, R. Salgado, H. Thorne, J. Visvader, P.J. Neeson, P.K. Darcy, S. Loi
Germline BRCA1 pathogenic variants and T cell dysfunction. // Immuno-Oncology and Technology. – URL: https://www.sciencedirect.com/science/article/pii/S2590018826000201?dgcid=rss_sd_all
Germline BRCA1 pathogenic variants and T cell dysfunction. Immuno-Oncology and Technology. https://www.sciencedirect.com/science/article/pii/S2590018826000201?dgcid=rss_sd_all
“Germline BRCA1 pathogenic variants and T cell dysfunction.” Immuno-Oncology and Technology.
@article{article48463,
title = {Germline BRCA1 pathogenic variants and T cell dysfunction},
journal = {Immuno-Oncology and Technology},
url = {https://www.sciencedirect.com/science/article/pii/S2590018826000201?dgcid=rss_sd_all}
}
Nature Reviews Cancer, Published online: 19 November 2026; doi:10.1038/s41568-026-01001-2 In this Journal Club, Chien-Han Kao and Ruey-Hwa Chen discuss a study showing that tumours use both de novo purine biosynthesis and purine salvage...
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01779-2 Targeting SMYD3 in cancer-associated fibroblasts relieves immune suppression and improves anti-PD-L1 response in HPV-negative HNSCC
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01786-3 Postoperative timing effects on AI-based resection-cavity segmentation in glioma: multi-site evaluation and relevance assessment